发明名称 Pharmaceutical compositions of Anisomelic acid and the use thereof
摘要 A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
申请公布号 US9623002(B2) 申请公布日期 2017.04.18
申请号 US201514827343 申请日期 2015.08.17
申请人 Eriksson John E.;Paul Preethy;Peuhu Emilia;Akbarsha M. A. 发明人 Eriksson John E.;Paul Preethy;Peuhu Emilia;Akbarsha M. A.
分类号 A61K9/66;A61K38/00;A61K31/34;C07D307/00;A61K31/343;A61K9/00;A61K47/10;A61K47/26;A61K9/107;A61K47/44 主分类号 A61K9/66
代理机构 Seppo Laine Oy 代理人 Seppo Laine Oy
主权项 1. A method of treating Human Papilloma Virus mediated cancers in a human, comprising administering a therapeutically effective amount of Anisomelic acid or salts thereof to said human.
地址 Turku FI